1/25/2010

The FDA approved Ampyra, making it the first recognized oral drug for treating multiple sclerosis. According to results of two Phase III clinical trials, the drug increased walking speed by about 25% in 35% and 43% of patients.

Full Story:
CNN

Related Summaries